Terms ending in 2032
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,233,076 | Controlled Release Dosage Forms In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,233,073 | Tamper Resistant Solid Oral Dosage Forms In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,703,962 | Monocyclic Compounds and Their Use as TRPV1 Ligands In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,759,362 | Bicycloheteroaryl Compounds and Their Use as TRPV1 Ligands In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,656,959 | Substituted Pyridines as Sodium Channel Blockers In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 8,688,465 | Pharmaceutical Representative Expense Report Management Software, Systems, and Methodologies In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,273,043 | TRPV1 Antagonists Including Dihydroxy Substituent and Uses Thereof In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | |
| US 9,630,959 | TRPV1 Antagonists Including Dihydroxy Substituent and Uses Thereof In force · Medium confidence | Shionogi & Co., Ltd. | In force | Medium confidence | |
| US 10,450,308 | TRPV1 Antagonists Including Dihydroxy Substituent and Uses Thereof In force · Medium confidence | Shionogi & Co., Ltd. | In force | Medium confidence | |
| US 9,818,124 | Methods for Sales Call Data Management and Processing In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| 15 more term ends in 2032 · Pro | |||||
10 of 25 patents shown. Soonest term end first, then patent number.
Pro members see all 25.
21 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.